www.fdanews.com/articles/187515-boston-scientific-to-acquire-cryterion-and-cryoablation-device-for-202-million
Boston Scientific to Acquire Cryterion and Cryoablation Device for $202 Million
July 6, 2018
Boston Scientific announced that it intends to buy Cryterion Medical’s approximately 65 percent remaining stake and its cryoablation device for $202 million.
The acquisition of the device will make Boston Scientific the first company to have both cryothermal and radiofrequency single-shot, balloon-based ablation therapies in its portfolio.
Single-shot ablation therapies, which deliver blasts of heat or cold to areas of the heart responsible for abnormal rhythm, are thought to be the fastest-growing subcategory in the global electrophysiology market.